BRIEF-Medicenna presents updates on phase 2b clinical trial of MDNA55 at annual meeting of society of neuro-oncology
1 分钟阅读
Nov 16 (Reuters) - Medicenna Therapeutics Corp
* Medicenna presents updates on phase 2b clinical trial of MDNA55 at the annual meeting of the society of neuro-oncology Source text for Eikon: Further company coverage: